Clincosm LogoSign in Get a demo

recurrent pancreatic carcinoma

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem

Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +11 more
  • Laboratory Biomarker Analysis
  • siRNA-transfected Peripheral Blood Mononuclear Cells APN401
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

Active, not recruiting
  • Colorectal Adenocarcinoma
  • +14 more
  • Atlanta, Georgia
  • +2 more
Jul 5, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage I Pancreatic Cancer AJCC v6 and v7 Trial in Omaha (drug, other,

Recruiting
  • Pancreatic Adenocarcinoma
  • +9 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 14, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 15, 2021

Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Oct 20, 2021

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (drug,

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Feb 8, 2018

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in Canada, United

Completed
  • Pancreatic Adenocarcinoma
  • +4 more
  • Akt Inhibitor MK2206
  • +3 more
  • Aurora, Colorado
  • +4 more
Aug 21, 2017

Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer Trial in Ann Arbor (Gemcitabine Hydrochloride, Laboratory Biomarker

Completed
Has Results
  • Recurrent Pancreatic Carcinoma
  • Stage IV Pancreatic Cancer
  • Gemcitabine Hydrochloride
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Aug 2, 2017

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Tucson, Arizona
  • +533 more
Feb 10, 2016